Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:HARP

Harpoon Therapeutics (HARP) Stock Price, News & Analysis

Harpoon Therapeutics logo

About Harpoon Therapeutics Stock (NASDAQ:HARP)

Advanced Chart

Key Stats

Today's Range
$23.01
$23.01
50-Day Range
$22.34
$23.01
52-Week Range
$3.11
$23.21
Volume
N/A
Average Volume
1.52 million shs
Market Capitalization
$389.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HARP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Harpoon Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

HARP Stock News Headlines

Does Merck Stock Have Room For Growth?
A $674B Industry Missed the Bigger Picture
TV video streaming exploded into a $674.25B market in 2024—driven by the hours we spend lost in entertainment. But there’s a much bigger habit consuming our time, with value that’s waiting to be unlocked. Smartphone screen time. We spend over 30 hours a week glued to our phones. Mode Mobile is pioneering ways to turn those hours into real income. Their EarnPhone unlocks 19 revenue streams from everyday phone use, helping users earn over $325M so far. Deloitte crowned them North America’s fastest-growing software company in 2023 after their revenue soared 32,481% from 2019-2022. But this industry is still in its infancy, and you can invest in the company that’s at the forefront of unlocking its value.
Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors
See More Headlines

HARP Stock Analysis - Frequently Asked Questions

Harpoon Therapeutics, Inc. (NASDAQ:HARP) announced its quarterly earnings data on Monday, March, 27th. The company reported ($5.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.70) by $0.80. The company earned $4.09 million during the quarter, compared to analyst estimates of $11.06 million. Harpoon Therapeutics had a negative trailing twelve-month return on equity of 893.55% and a negative net margin of 81.68%.

Shares of Harpoon Therapeutics reverse split on the morning of Tuesday, September 5th 2023.The 1-10 reverse split was announced on Tuesday, September 5th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, September 5th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Harpoon Therapeutics (HARP) raised $76 million in an initial public offering on Friday, February 8th 2019. The company issued 5,400,000 shares at $13.00-$15.00 per share. Citigroup and Leerink Partners served as the underwriters for the IPO and Canaccord Genuity and Wedbush PacGrow were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Harpoon Therapeutics investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), CrowdStrike (CRWD), Arista Networks (ANET) and Adobe (ADBE).

Company Calendar

Last Earnings
3/27/2023
Today
7/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:HARP
CIK
1708493
Fax
N/A
Employees
53
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($8.76)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$67.73 million
Net Margins
-81.68%
Pretax Margin
-81.67%
Return on Equity
-893.55%
Return on Assets
-45.98%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.89
Quick Ratio
1.89

Sales & Book Value

Annual Sales
$37.34 million
Price / Sales
10.43
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.63 per share
Price / Book
14.12

Miscellaneous

Outstanding Shares
16,932,000
Free Float
14,054,000
Market Cap
$389.61 million
Optionable
Optionable
Beta
2.11
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:HARP) was last updated on 7/28/2025 by MarketBeat.com Staff
From Our Partners